| [1] |
王继,刘合作.新生儿高胆红素血症围生期影响因素分析[J].现代实用医学, 2023, 35(7):925-927.
|
| [2] |
涂阳阳, 原新慧, 李宇宁. 新生儿胆红素脑病的发病机制及诊治进展[J]. 医学综述, 2021,27(16): 3160-3166.
|
| [3] |
中华医学会儿科学分会新生儿学组,《中华儿科杂志》编辑委员会. 新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志,2014,52(10):745-748.
|
| [4] |
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics, 2004,114(1):297-316.
|
| [5] |
熊丽辉,高婷婷,王承湘,等.基于机器算法的脑梗死多模态“脉-病”预测模型研究[J/OL].世界中医药,1-11[2025-12-31].
|
| [6] |
程丽,刘琼娜,蒋晶晶.妊娠期糖尿病血糖控制水平与新生儿高胆红素血症发病的相关性[J].中国妇幼健康研究,2024,35(2):64-73.
|
| [7] |
Dey SK, Islam S, Jahan I, et al. Association of hyperbilirubinemia requiring phototherapy or exchange transfusion with hearing impairment among admitted term and late preterm newborn in a NICU[J]. Mymensingh Med J, 2020,29(2):405-413.
|
| [8] |
Mutlu M, Aslan Y, Kader Ş, et al. Preventive effects of probiotic supplementation on neonatal hyperbilirubinemia caused by isoimmunization[J]. Am J Perinatol, 2020,37(11):1173-1176.
|
| [9] |
恽雯昕,范建霞. 孕前糖尿病对妊娠的影响[J]. 中国实用妇科与产科杂志,2025,41(4):400-404.
|
| [10] |
Yang ST, Liu FC, Chen HL. Comparison of transcutaneous and serum bilirubin before, under, and after phototherapy in term and late-preterm infants[J]. Kaohsiung J Med Sci, 2019, 35(11): 715-724.
|
| [11] |
Soliman A, Salama H, Al Rifai H, et al. The effect of different forms of dysglycemia during pregnancy on maternal and fetal outcomes in treated women and comparison with large cohort studies[J]. Acta Biomed, 2018, 89(S5): 11-21.
|
| [12] |
郑芳慧,张阳,邹丽.高龄肥胖女性再次妊娠代谢性疾病的预防和管理[J].中国实用妇科与产科杂志,2023,39(6):593-597.
|
| [13] |
田青,李晓东,查文清,等.新生儿高胆红素血症危险因素的Logistic分析[J].实用医学杂志,2011,27(14):2560-2562.
|
| [14] |
李翠莹,李小薇.胎儿新生儿溶血病实验室检测专家共识[J].临床输血与检验, 2021, 23(1):20-23.
|
| [15] |
程晨,张怡,陈怡静,等.吸收IgG抗-AB抗体后IgG抗-A/抗-B抗体效价预测ABO-胎儿新生儿溶血病的价值[J].中国实验血液学杂志,2024,32(6):1903-1908.
|
| [16] |
Li P, Pang LH, Liang HF, et al. Maternal IgG anti-A and anti-B titer levels screening in predicting ABO hemolytic disease of the newborn: a meta-analysis[J]. Fetal Pediatr Pathol, 2015, 34(6): 341-350.
|
| [17] |
贾丹,蒋莎,李娜,等.妊娠期ABO抗体阳性的研究进展[J].中国免疫学杂志, 2019, 35(18):2302-2306.
|
| [18] |
周晋宇,沈茹,吴翰欣,等.云南地区283例ABO系统新生儿溶血病检测结果分析[J].中国实验血液学杂志,2025,33(3):881-885.
|
| [19] |
刘凡,严争,危夷,等. 新生儿高胆红素血症的危险因素分析(附365例报告)[J]. 福建医药杂志,2016,38(6):16-17.
|
| [20] |
王秀兰.新生儿高胆红素血症的病因分析及临床处理方法探讨[J].临床医药文献电子杂志,2016,3(31):6158,6160.
|
| [21] |
陈秀, 李业瑜, 许立伦. 新生儿高胆红素血症影响因素分析[J]. 中国儿童保健杂志, 2014,22(1): 77-79.
|
| [22] |
舒春兰,邓爱果,晏菲琴,等.足月新生儿高胆红素血症影响因素的流行病学调查[J].江西医药,2022,57(10):1681-1683.
|
| [23] |
刘岩,杨春侠,张莹.新生儿黄疸128例病因探讨及中西医结合疗效分析[J].中国现代医生,2021,59(35):70-73.
|
| [24] |
左爽, 李景, 华子瑜. 1990—2019年全球新生儿黄疸疾病负担分析[J]. 中国当代儿科杂志, 2023,25(10): 1008-1015.
|
| [25] |
Lin Q, Zhu D, Chen C, et al. Risk factors for neonatal hyperbilirubinemia: a systematic review and meta-analysis[J]. Transl Pediatr, 2022,11(6):1001-1009.
|
| [26] |
吴菲,冯向春,付蓉,等.新生儿高胆红素血症相关影响因素Logistic回归分析[J].河北医科大学学报,2018,39(3):351-354.
|
| [27] |
Cai Y, Li X, Wang P, et al. Predictive factors for readmission due to neonatal hyperbilirubinemia: A retrospective case-control study[J]. PLoS One, 2025,20(4):e0320767.
|
| [28] |
Vidavalur R, Devapatla S. Trends in hospitalizations of newborns with hyperbilirubinemia and kernicterus in United States: an epidemiological study[J]. J Matern Fetal Neonatal Med, 2022, 35(25): 7701-7706.
|
| [29] |
黄家虎, 孙建华. 新生儿高胆红素血症病因的研究进展[J]. 医学综述, 2021,27(4): 680-684.
|
| [30] |
Zhang K, Fan S, Lv A, et al. Integrated analysis of microbiota with bile acids for the phototherapy treatment of neonatal jaundice[J]. Arch Med Sci, 2021,19(2):401-410.
|
| [31] |
Lin C, Lin Y, Xiao R, et al. Bifidobacterium species associated with breastfeeding alleviate neonatal hyperbilirubinaemia via the gut microbiota-α-linolenic and linoleic acid metabolism-enterohepatic circulation axis[J]. Microbiome, 2025,13(1):187.
|
| [32] |
Li Z, Zhang Y, Luo X, et al. Dynamic relationships between bilirubin concentrations and the gut microbiota in the neonatal period: A pilot prospective cohort study[J]. Pediatr Investig, 2025,9(4):347-360.
|